Titel

Merkliste
1 Ergebnisse

Vismodegib in patients with advanced basal cell carcinoma: ..:

Basset-Séguin, N ; Hauschild, A ; Kunstfeld, R...
info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022. , 2017

Link: https://hal.science/hal-01743310

RT Journal
T1 <Title>Vismodegib in patients with advanced basal cell carcinoma: Primary analysis of STEVIE, an international, open-label trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftunivaixmarseil:oai:HAL:hal-01743310v1&Exemplar=1&LAN=DE
				
A1 Basset-Séguin, N
A1 Hauschild, A
A1 Kunstfeld, R
A1 Grob, J
A1 Dréno, B
A1 Mortier, L
A1 Ascierto, P. A
A1 Licitra, L
A1 Dutriaux, C
A1 Thomas, L
A1 Meyer, N
A1 Guillot, B
A1 Dummer, R
A1 Arenberger, P
A1 Fife, K
A1 Raimundo, A
A1 Dika, E
A1 Dimier, N
A1 Fittipaldo, A
A1 Xynos, I
A1 Hansson, J
PB HAL CCSD; Elsevier
YR 2017
K1 Humans
K1 Female
K1 Male
K1 Adolescent
K1 Administration
K1 Oral
K1 Adult
K1 Aged
K1 Antineoplastic Agents
K1 Disease-Free Survival
K1 Drug Administration Schedule
K1 Kaplan-Meier Estimate
K1 Middle Aged
K1 Treatment Outcome
K1 80 and over
K1 Anilides
K1 Basal cell carcinoma
K1 Basal Cell Nevus Syndrome
K1 Carcinoma
K1 Basal Cell
K1 Creatine Kinase
K1 Disease Progression
K1 Gorlin syndrome
K1 Hedgehog pathway inhibitor
K1 Pyridines
K1 Spasm
K1 STEVIE
K1 Time Factors
K1 Vismodegib
K1 Young Adult
K1 [SDV.CAN]Life Sciences [q-bio]/Cancer
K1 [SDV.MHEP.DERM]Life Sciences [q-bio]/Human health and pathology/Dermatology
K1 [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology
JF info:eu-repo/semantics/altIdentifier/doi/10.1016/j.ejca.2017.08.022
LK http://dx.doi.org/https://hal.science/hal-01743310
DO https://hal.science/hal-01743310
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)